185 related articles for article (PubMed ID: 7535469)
1. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
Series HG; Cowen PJ; Sharp T
Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469
[TBL] [Abstract][Full Text] [Related]
2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
3. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Berger UV; Gu XF; Azmitia EC
Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
[TBL] [Abstract][Full Text] [Related]
4. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA).
Mamounas LA; Molliver ME
Exp Neurol; 1988 Oct; 102(1):23-36. PubMed ID: 2846339
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Fattaccini CM; Gozlan H; Hamon M
Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
[TBL] [Abstract][Full Text] [Related]
6. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
[TBL] [Abstract][Full Text] [Related]
7. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
Wichems CH; Hollingsworth CK; Bennett BA
Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
9. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
[TBL] [Abstract][Full Text] [Related]
10. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
11. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic pretreatment with D-fenfluramine or p-chloroamphetamine on [3H]inositolmonophosphate accumulation in rat cortical miniprisms.
Erfurth A; Gardier AM; Ribeiro E; Wurtman RJ
Brain Res; 1994 Nov; 665(1):107-14. PubMed ID: 7882002
[TBL] [Abstract][Full Text] [Related]
13. Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines.
Series HG; le Masurier M; Gartside SE; Franklin M; Sharp T
J Psychopharmacol; 1995 Jan; 9(3):214-22. PubMed ID: 22297760
[TBL] [Abstract][Full Text] [Related]
14. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
15. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
Baumann MH; Ayestas MA; Dersch CM; Rothman RB
Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
[TBL] [Abstract][Full Text] [Related]
16. D-fenfluramine selectively releases 5-HT from dorsal raphe terminals.
Viana MB; Silveira R; Graeff FG
Braz J Med Biol Res; 1996 May; 29(5):639-42. PubMed ID: 9033815
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
Gartside SE; McQuade R; Sharp T
J Pharmacol Exp Ther; 1996 Oct; 279(1):277-83. PubMed ID: 8859004
[TBL] [Abstract][Full Text] [Related]
18. Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex.
Wright IK; Garratt JC; Marsden CA
Br J Pharmacol; 1990 Feb; 99(2):221-2. PubMed ID: 1691671
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
20. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
